FDA warned Phuoc Loc Tho Herbals that its herbal products are unapproved new drugs marketed with disease claims.
What happened
FDA reviewed the company’s website in August and September 2026. It found three products marketed with claims to treat conditions such as gout, pain, strokes, heart failure, and kidney failure, making them unapproved new drugs with no approved FDA application. FDA also said the site offers four other products, and earlier lab tests of similarly named products found undeclared drug ingredients, though FDA had not sampled these versions from the company’s inventory.
What FDA found
The products are drugs because their website labeling claims they treat diseases such as gout, pain, strokes, heart failure, and kidney failure.
FD&C Act section 201(g)(1), 21 U.S.C. 321(g)(1)The products are “new drugs” not generally recognized as safe and effective, and FDA has no approved application for them.
FD&C Act sections 201(p) and 505(a), 21 U.S.C. 321(p) and 355(a)Selling these unapproved drugs across state lines violates the FD&C Act.
FD&C Act sections 301(d) and 505(a), 21 U.S.C. 331(d) and 355(a)FDA said four other products are offered on the site, and earlier tests of similarly named products found undeclared drug ingredients, though these inventory versions were not tested.
What FDA wants
FDA tells the company to correct the violations and respond in writing within 15 business days with the steps taken, steps to prevent recurrence, and supporting documents, using reference number 736860.
Who should pay attention
- companies selling imported herbal remedies online
- brands sourcing or repackaging similar Asian herbal products
- retailers and online marketplaces listing these products
This is a summary. Read the original letter on fda.gov.